BlossomHill Therapeutics Stock (BLSM) Fails to Shine After $150M U.S. IPO
Shares in cancer-focused biotech firm BlossomHill Therapeutics ($BLSM) dropped nearly 3% in its stock market debut after it raised $150 million in ...
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 5,000,040 | $19,500.16 | 0 | 2012-06-22 | Filing | |
| $0.01 | 250,002 | $1,500.01 | 1,748,798 | 2010-08-12 | Filing | |
| $0.01 | 250,002 | $1,500.01 | 1,749,998 | 2010-08-12 | Filing |